Howard Y. Chang
Howard Y. Chang | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 張元豪 | |||||||||||
| Born | Chang Yuan-hao January 11, 1972 Taipei, Taiwan | ||||||||||
| Education | Harvard University (BA, MD) Massachusetts Institute of Technology (PhD) | ||||||||||
| Known for | Long non-coding RNA | ||||||||||
| Father | Chang Chau-hsiung | ||||||||||
| Scientific career | |||||||||||
| Fields | Molecular biology | ||||||||||
| Workplaces | Stanford University | ||||||||||
| Thesis | Molecular studies of Fas signaling and programmed cell death (1998) | ||||||||||
| David Baltimore | |||||||||||
Other academic advisors | |||||||||||
| Chinese name | |||||||||||
| Traditional Chinese | 張元豪 | ||||||||||
| Simplified Chinese | 张元豪 | ||||||||||
| |||||||||||
Howard Yuan-hao Chang (Chinese: 張元豪; pinyin: Zhāng Yuánháo; born January 11, 1972) is a Taiwanese-American physician-scientist and molecular biologist. He is the Virginia and D. K. Ludwig Professor of Cancer Research at Stanford University, where he is also a joint professor of dermatology, genetics, and pathology at the Stanford University School of Medicine.
Since 2024, Chang has been the senior vice president of research and chief scientific officer of Amgen. From 2018 to 2024, he was a Howard Hughes Medical Institute investigator. He is best known for his research on long non-coding RNAs.